Publication list
*Human clinical trials
PS128™
Increased athletic endurance and gut microbiota in athletes
Enhanced neural physiology and reduced Parkinson’s disease-like symptoms
Ameliorated symptoms of IBS
04*
Alleviated symptoms of ASD in children
Regulated dopamine and reduced Tourette syndrome-like behavior
Reduced oxidateive stress and increased both exercise performance and serum branch-chain amino acid levels in athletes
Deemed safe for human consumption
Lowered anxiety- and depression-like behaviors and regulated related brain neurochemicals under stressed conditions
Regulated brain dopamine and serotonin levels, increased locomotor activity, and decreased anxiety-like behaviors
PS23™
Resulted in diminished anxiety- and depression-like symptoms, stress hormones, and inflammation under stress conditions
Ameliorated age-related loss of muscle mass and strength and physiological markers
Raised BDNF levels as well as reduced depression- and anxiety-like behaviors and related hormone levels
Lessened cognitive, behavioral, and physiological signs of aging
A17
Regulated immune responses
K37
Modulated allergic reactions
K21
Lowered body weight and regulated lipid markers